Please use this identifier to cite or link to this item: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3482
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaz-Ares, Luis-
dc.contributor.authorSpigel, David R.-
dc.contributor.authorChen, Yuanbin-
dc.contributor.authorJove, Maria-
dc.contributor.authorJuan-Vidal, Oscar-
dc.contributor.authorRich, Patricia-
dc.contributor.authorHayes, Theresa M.-
dc.contributor.authorGutiérrez Calderón, Vanesea-
dc.contributor.authorCaro, Reyes Bernabe-
dc.contributor.authorNavarro, Alejandro-
dc.contributor.authorDowlati, Afshin-
dc.contributor.authorZhang, Bin-
dc.contributor.authorMoore, Yan-
dc.contributor.authorYao, Xiaopan-
dc.contributor.authorKokhreidze, Jaba-
dc.contributor.authorPonce, Santiago-
dc.contributor.authorBunn, Paul-
dc.date.accessioned2023-03-17T04:57:11Z-
dc.date.available2023-03-17T04:57:11Z-
dc.date.issued2021-
dc.identifier.urihttps://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3482-
dc.description.abstractIntroduction Many patients with small cell lung cancer (SCLC) develop drug resistance to first-line platinum-based chemotherapy, and second-line therapies are limited. RESILIENT (ClinicalTrials.gov identifier NCT03088813) is a two-part phase 2/3 study assessing the safety, tolerability and efficacy of liposomal irinotecan monotherapy as second-line treatment for patients with SCLC. Here we report data from part 1 of the RESILIENT study (data cut off, 2 December 2019).-
dc.titleFP10.04 RESILIENT Part 1: Safety and Efficacy of Second-Line Liposomal Irinotecan in Patients with Small Cell Lung Cancer-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of Thoracic Oncology-
dc.identifier.urlhttps://dx.doi.org/10.1016/j.jtho.2021.01.126-
dc.source.volume16-
local.issue.number3-
dc.identifier.importdoi10.1016/j.jtho.2021.01.126-
dc.contributor.swhauthorHayes, Theresa M.-
Appears in Collections:SWH Staff Publications



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing